Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors Post author:Sam Post published:August 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Merck's Ace Keytruda Flunks Key Phase III Stomach Cancer Study December 14, 2017 Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017 Ag Biotech Company Announces $24MM C Round Financing July 9, 2017
Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017